Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. 

Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by EMA to the European Committee (EC), the EC has granted Marketing Authorisation for Vueway (gadopiclenol) in the European Union
News | Contrast Media
The European Commission Grants Marketing Authorization to Bracco Imaging for Vueway (gadopiclenol) Contrast Agent in the European Union

December 11, 2023 — Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions ...

Time December 11, 2023
arrow
Licensing agreement between Philochem and Blue Earth Diagnostics, one of the Bracco family of companies, encompasses applications of OncoFAP for diagnostic and medical imaging
News | Radiopharmaceuticals and Tracers
Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
The new AI-enabled MRI system makes high performance wide bore the standard for true patient comfort, and will showcase existing AI and deep learning powered solutions that help enable faster and more precise scans, according to GE HealthCare during RSNA 2023.
News | RSNA
GE Healthcare Launches New AI-enabled MRI System at RSNA23

December 1, 2023 — In today's healthcare environment, the industry faces various pressing challenges. The magnetic ...

Time December 01, 2023
arrow
GE HealthCare is proud to announce the addition of True Enhance DL to its Effortless Recon DL portfolio
News | Radiology Imaging
GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023

November 30, 2023 — Through its leading imaging solutions and commitment to innovation, GE HealthCare remains at the ...

Time November 30, 2023
arrow
Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry Services brand, at the 2023 Radiological Society of North America (RSNA) Meeting
News | Quality Assurance (QA)
Mirion Medical Introduces Instadose VUE Dosimeter at Radiological Society of North America (RSNA) Annual Meeting

November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...

Time November 25, 2023
arrow
The new Siemens Healthineers system offers 20% performance improvement boost throughput
News | PET-CT
Siemens Healthineers Announces FDA Clearance of Biograph Vision.X PET/CT Scanner

November 22, 2023 — Siemens Healthineers has announced the U.S. Food and Drug Administration (FDA) clearance of the ...

Time November 22, 2023
arrow
AI-powered NeuroShield automatically quantifies brain volumes using MRI data – the first of its kind with the capability to provide ethnicity-specific reference ranges
News | Artificial Intelligence
Heuron Showcasing Neuro AI Solutions and Presenting Abstract on AI Solutions for Stroke at RSNA23

November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...

Time November 21, 2023
arrow
IONIC Health will add multi-vendor, multi-modality remote scanning capabilities to GE HealthCare's portfolio of effortless operations solutions, including the recently FDA-cleared Digital Expert Access with remote scanning
News | Information Technology
GE HealthCare Announces New Version of Digital Expert Access, the First FDA 510(k)-Cleared Device to Enable Remote Patient Scanning, and Exclusive Distribution Agreement with IONIC Health

November 21, 2023 — GE HealthCare has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access ...

Time November 21, 2023
arrow
A biomarker of norepinephrine deficiency in the heart may help to detect Lewy body diseases before symptoms appear
News | PET Imaging
PET Scans May Predict Parkinson’s Disease and Lewy Body Dementia in At-risk Individuals

November 8, 2023 — In a small study, researchers at the National Institutes of Health have found that positron emission ...

Time November 08, 2023
arrow
Meilleur Technologies, Inc. announced a research collaboration agreement with the National Institute of Aging (NIA)-sponsored multicenter study called the Consortium for Clarity in ADRD Research Through Imaging (CLARiTI).
News | PET Imaging
Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the NIA-sponsored CLARiTI Trial

November 6, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the National Institute ...

Time November 06, 2023
arrow
Paige Lymph Node detects the presence of breast cancer metastases with near-perfect sensitivity with the power of AI
News | PET Imaging
PET imaging: Aggressive Brain Tumors Will Soon Be Treated More Effectively

October 26, 2023 — A more refined approach to the precise removal of brain tumors is on the horizon. The long ...

Time October 26, 2023
arrow
Elekta wins public tender to deliver several Harmony linear accelerators to help meet demand for cancer treatments
News | Linear Accelerators
Elekta Continues to Support Ukrainian Cancer Patients with Latest Radiation Therapy Equipment

October 25, 2023 — A new order for several Elekta Harmony linear accelerators (linacs) in Ukraine will complement the ...

Time October 25, 2023
arrow
The Centers for Medicare and Medicaid Services (CMS) recently released its final National Coverage Determination Reconsideration for Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease
News | PET Imaging
CMS Responds to Public Comments Received on Beta Amyloid PET Scan Proposed Coverage

October 24, 2023 — The Centers for Medicare and Medicaid Services (CMS) recently released its final National Coverage ...

Time October 24, 2023
arrow
Comprehensive restoration of legacy machine offers the opportunity for sustainable solution
News | Proton Therapy
IBA Plans Total System Restoration on its First-ever Proton Therapy Installation

October 23, 2023 — IBA, a world leader in particle accelerator technology and the world’s leading provider of proton ...

Time October 23, 2023
arrow
Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease Neuroimaging Initiative 4, ADNI4
News | Radiopharmaceuticals and Tracers
Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI4)

October 20, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease ...

Time October 20, 2023
arrow
Human life-like in vitro model of radiation damage sustained to the lung opens an unprecedented window into the early disease process, and opportunities for drug development
News | Radiation Therapy
Human Lung Chip Leveraged to Faithfully Model Radiation-induced Lung Injury

October 19, 2023 — The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high ...

Time October 19, 2023
arrow
Medicare leaves coverage determination for amyloid PET in dementia care to MACs
News | PET Imaging
CMS Expands Access to Beta Amyloid PET for Medicare Beneficiaries

October 18, 2023 — The Centers for Medicare and Medicaid Services (CMS) announced it will no longer require coverage ...

Time October 18, 2023
arrow
New company will advance Actinium-225 technologies
News | Radiopharmaceuticals and Tracers
ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of Actinium-225

October 18, 2023 —ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Canadian ...

Time October 18, 2023
arrow
Radionetics initiates its first clinical program targeting MC2R
News | Radiation Oncology
Radionetics Oncology Announces Initiation of Phase 1 Radiopharmaceutical Program Against a Novel Target for Adrenocortical Carcinoma

October 17, 2023 — Radionetics Oncology, Inc., a clinical stage radiopharmaceutical company focused on the discovery and ...

Time October 17, 2023
arrow
A global licensing agreement has been signed for the development and commercialization of SOFIE’s two investigational Gallium-68 and Fluorine-18 Fibroblast Activation Protein Inhibitors (FAPI) radiopharmaceutical diagnostics - [68Ga]FAPI-46 and outside-U.S. rights for [18F]FAPI-74
News | Radiopharmaceuticals and Tracers
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE) ...

Time October 11, 2023
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now